These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32423354)

  • 1. Cortical thickness and gyrification index measuring cognition in Parkinson's disease.
    Chaudhary S; Kumaran SS; Goyal V; Kaloiya GS; Kalaivani M; Jagannathan NR; Sagar R; Mehta N; Srivastava AK
    Int J Neurosci; 2021 Oct; 131(10):984-993. PubMed ID: 32423354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortical thinning correlates of changes in visuospatial and visuoperceptual performance in Parkinson's disease: A 4-year follow-up.
    Garcia-Diaz AI; Segura B; Baggio HC; Uribe C; Campabadal A; Abos A; Marti MJ; Valldeoriola F; Compta Y; Bargallo N; Junque C
    Parkinsonism Relat Disord; 2018 Jan; 46():62-68. PubMed ID: 29132765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortical thinning across Parkinson's disease stages and clinical correlates.
    Wilson H; Niccolini F; Pellicano C; Politis M
    J Neurol Sci; 2019 Mar; 398():31-38. PubMed ID: 30682518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tracking Cortical Changes Throughout Cognitive Decline in Parkinson's Disease.
    Filippi M; Canu E; Donzuso G; Stojkovic T; Basaia S; Stankovic I; Tomic A; Markovic V; Petrovic I; Stefanova E; Kostic VS; Agosta F
    Mov Disord; 2020 Nov; 35(11):1987-1998. PubMed ID: 32886420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortical Thinning and Cognitive Impairment in Parkinson's Disease without Dementia.
    Zhang L; Wang M; Sterling NW; Lee EY; Eslinger PJ; Wagner D; Du G; Lewis MM; Truong Y; Bowman FD; Huang X
    IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(2):570-580. PubMed ID: 29610105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinson's disease with mild cognitive impairment: severe cortical thinning antedates dementia.
    Gasca-Salas C; García-Lorenzo D; Garcia-Garcia D; Clavero P; Obeso JA; Lehericy S; Rodríguez-Oroz MC
    Brain Imaging Behav; 2019 Feb; 13(1):180-188. PubMed ID: 28710667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortical atrophy patterns in early Parkinson's disease patients using hierarchical cluster analysis.
    Uribe C; Segura B; Baggio HC; Abos A; Garcia-Diaz AI; Campabadal A; Marti MJ; Valldeoriola F; Compta Y; Tolosa E; Junque C
    Parkinsonism Relat Disord; 2018 May; 50():3-9. PubMed ID: 29449187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson's disease longitudinally.
    Hanganu A; Bedetti C; Degroot C; Mejia-Constain B; Lafontaine AL; Soland V; Chouinard S; Bruneau MA; Mellah S; Belleville S; Monchi O
    Brain; 2014 Apr; 137(Pt 4):1120-9. PubMed ID: 24613932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortical atrophy is associated with cognitive impairment in Parkinson's disease: a combined analysis of cortical thickness and functional connectivity.
    Zhu Y; Yang B; Zhou C; Gao C; Hu Y; Yin WF; Yin K; Zhu Y; Jiang G; Ren H; Pang A; Yang X
    Brain Imaging Behav; 2022 Dec; 16(6):2586-2600. PubMed ID: 36044168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical thinning is associated with disease stages and dementia in Parkinson's disease.
    Zarei M; Ibarretxe-Bilbao N; Compta Y; Hough M; Junque C; Bargallo N; Tolosa E; Martí MJ
    J Neurol Neurosurg Psychiatry; 2013 Aug; 84(8):875-81. PubMed ID: 23463873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical thinning associated with mild cognitive impairment in Parkinson's disease.
    Segura B; Baggio HC; Marti MJ; Valldeoriola F; Compta Y; Garcia-Diaz AI; Vendrell P; Bargallo N; Tolosa E; Junque C
    Mov Disord; 2014 Oct; 29(12):1495-503. PubMed ID: 25100674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal brain atrophy distribution in advanced Parkinson's disease: What makes the difference in "cognitive status" converters?
    Gorges M; Kunz MS; Müller HP; Liepelt-Scarfone I; Storch A; Dodel R; Hilker-Roggendorf R; ; Berg D; Kalbe E; Braak H; Del Tredici K; Baudrexel S; Huppertz HJ; Kassubek J
    Hum Brain Mapp; 2020 Apr; 41(6):1416-1434. PubMed ID: 31789477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mild cognitive impairment in patients with Parkinson's disease is associated with increased cortical degeneration.
    Hanganu A; Bedetti C; Jubault T; Gagnon JF; Mejia-Constain B; Degroot C; Lafontaine AL; Chouinard S; Monchi O
    Mov Disord; 2013 Sep; 28(10):1360-9. PubMed ID: 23801590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topologically convergent and divergent morphological gray matter networks in early-stage Parkinson's disease with and without mild cognitive impairment.
    Suo X; Lei D; Li N; Li J; Peng J; Li W; Yang J; Qin K; Kemp GJ; Peng R; Gong Q
    Hum Brain Mapp; 2021 Oct; 42(15):5101-5112. PubMed ID: 34322939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortical thickness in de novo patients with Parkinson disease and mild cognitive impairment with consideration of clinical phenotype and motor laterality.
    Danti S; Toschi N; Diciotti S; Tessa C; Poletti M; Del Dotto P; Lucetti C
    Eur J Neurol; 2015 Dec; 22(12):1564-72. PubMed ID: 26212370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct serum GDNF coupling with brain structural and functional changes underlies cognitive status in Parkinson's disease.
    Tang C; Sun R; Xue K; Wang M; Liang S; Kambey PA; Shi M; Wu C; Chen G; Gao D
    CNS Neurosci Ther; 2024 Mar; 30(3):e14461. PubMed ID: 37718594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired topological properties of cortical morphological brain networks correlate with motor symptoms in Parkinson's disease.
    Yan S; Lu J; Li Y; Tian T; Zhou Y; Zhu H; Qin Y; Zhu W
    J Neuroradiol; 2024 Jun; 51(4):101155. PubMed ID: 37774912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphometric magnetic resonance imaging cortico-subcortical features in Parkinson's disease with mild cognitive impairment.
    Cicero CE; Donzuso G; Luca A; Davì M; Baschi R; Mostile G; Giuliano L; Palmucci S; Salerno A; Monastero R; Nicoletti A; Zappia M
    Eur J Neurol; 2022 Nov; 29(11):3197-3204. PubMed ID: 35790057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial cognitive decline is associated with cortical thinning in early Parkinson disease.
    Pereira JB; Svenningsson P; Weintraub D; Brønnick K; Lebedev A; Westman E; Aarsland D
    Neurology; 2014 Jun; 82(22):2017-25. PubMed ID: 24808018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.